Since the mechanism mediating hypertension in BPH/2J mice appears to be independent of central AT1 receptor activity, it is not surprising that there was minimal effect on BP following treatment with the SOD mimetic tempol or resveratrol which has ROS scavenging properties (Leonard et al., 2003). Here, AGTR1 is linked to benign prostatic hyperplasia.